Researcher
Pieter Colin
- Disciplines:Small molecules, Clinical pharmacy, Pharmaceutical care, Pharmacotherapy, Drug discovery and development not elsewhere classified, Clinical trials, Compound screening, In vitro testing, Other mathematical sciences and statistics not elsewhere classified, Non-clinical studies
Affiliations
- Department of Bio-analysis (Department)
Member
From1 Sep 2009 → 31 Oct 2020
Projects
1 - 1 of 1
- Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to BedsideFrom1 Jan 2016 → 9 Oct 2021Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 49
- PKPD modeling and dosing considerations in advanced ovarian cancer patients treated with cisplatin-based intraoperative intraperitoneal chemotherapy(2020)
Authors: Feifan Xie, Jan Van Bocxlaer, Pieter Colin, Charlotte Carlier, Olivier Van Kerschaver, Joseph Weerts, Hannelore Denys, Philippe Tummers, Wouter Willaert, Wim Ceelen, et al.
- Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations(2020)
Authors: Douglas J. Eleveld, Pieter Colin, Anthony R. Absalom, Michel Struys
Pages: 483 - 491 - A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers(2019)
Authors: Feifan Xie, An Vermeulen, Pieter Colin, Zeneng Cheng
Pages: 1003 - 1014 - Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia(2019)
Authors: Feifan Xie, Konstantinos Mantzarlis, Polychronis Malliotakis, Vasileios Koulouras, Despoina Koulenti, Koen Boussery, Pieter Colin
Pages: 667 - 674 - Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.(2019)
Authors: Feifan Xie, Kaat De Clercq, Chris Vervaet, Jan Van Bocxlaer, Pieter Colin, An Vermeulen
- Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem : a comparison of eight pharmacokinetic models(2019)
Authors: Sofie Dhaese, Andras Farkas, Pieter Colin, Jeffrey Lipman, Veronique Stove, Alain Verstraete, Jason A Roberts, Jan De Waele
Pages: 432 - 441 - Pharmacodynamic interaction of remifentanil and dexmedetomidine on depth of sedation and tolerance of laryngoscopy(2019)
Authors: Maud A. S. Weerink, Clemens R. M. Barends, Ernesto R. R. Muskiet, Koen M. E. M. Reyntjens, Froukje H. Knotnerus, Martine Oostra, Jan Van Bocxlaer, Michel Struys, Pieter Colin
Pages: 1004 - 1017 - Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level(2019)
Authors: Griet Van Lancker, Lucas Van Bortel, Brant Delafontaine, Koen Boussery, Eleonora Swart, Abdel Chahbouni, Jan Van Bocxlaer, Pieter Colin
Pages: 195 - 203 - Vancomycin pharmacokinetics throughout life : results from a pooled population analysis and evaluation of current dosing recommendations(2019)
Authors: Pieter Colin, Karel Allegaert, Alison H Thomson, Daan J Touw, Michael Dolton, Matthijs de Hoog, Jason A Roberts, Eyob D Adane, Masato Yamamoto, Dolores Santos-Buelga, et al.
Pages: 767 - 780 - Saturable elimination of piperacillin in critically ill patients : implications for continuous infusion(2019)
Authors: Sofie Dhaese, Pieter Colin, Helena Willems, A Heffernan, Bram Gadeyne, Sarah Van Vooren, Pieter Depuydt, Eric Hoste, Veronique Stove, Alain Verstraete, et al.
Pages: 741 - 749